Search research articles
Contact Us
Filters
Showing results (161-170 of 171) with videos related to
Page
of 18
Sort By:
Neuro-Oncology
|
October 11, 2017
Phase I/II trial of vorinostat combined with temozolomide and radiation therapy for newly diagnosed glioblastoma: results of Alliance N0874/ABTC 02
Evanthia Galanis, S Keith Anderson, C Ryan Miller, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 12, 2007
Adult cancer pain
Robert Swarm, Doralina L Anghelescu, Costantino Benedetti, et al.
Journal for Immunotherapy of Cancer
|
August 12, 2021
Pembrolizumab for patients with leptomeningeal metastasis from solid tumors: efficacy, safety, and cerebrospinal fluid biomarkers
Jarushka Naidoo, Karisa C Schreck, Wei Fu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 17, 2025
Phase I Study of Adavosertib with Radiotherapy and Temozolomide in Newly Diagnosed Glioblastoma and Intratumoral Drug Levels in Recurrent Glioblastoma
Eudocia Q Lee, Brian M Alexander, Carlos G Romo, et al.
Neuro-Oncology
|
July 18, 2020
CODEL: phase III study of RT, RT + TMZ, or TMZ for newly diagnosed 1p/19q codeleted oligodendroglioma. Analysis from the initial study design
Kurt A Jaeckle, Karla V Ballman, Martin van den Bent, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 22, 2008
Central nervous system cancers
Steven S Brem, Philip J Bierman, Peter Black, et al.
Neuro-Oncology
|
August 12, 2021
Multimodal platform for assessing drug distribution and response in clinical trials
Begoña G C Lopez, Ishwar N Kohale, Ziming Du, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 1, 2005
Central nervous system cancers: Clinical Practice Guidelines in Oncology
Steven S Brem, Philip J Bierman, Peter Black, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 30, 2024
Surgical window of opportunity trial reveals mechanisms of response and resistance to navtemadlin (KRT-232) in patients with recurrent glioblastoma
Veronica Rendo, Eudocia Q Lee, Connor Bossi, et al.
Science Translational Medicine
|
February 19, 2025
A window-of-opportunity trial reveals mechanisms of response and resistance to navtemadlin in patients with recurrent glioblastoma
Veronica Rendo, Eudocia Q Lee, Connor Bossi, et al.
Page
of 18
Search research articles
Search
Showing results (161-170 of 171) with videos related to
Sort By:
Page
of 18
Neuro-Oncology
|
October 11, 2017
Phase I/II trial of vorinostat combined with temozolomide and radiation therapy for newly diagnosed glioblastoma: results of Alliance N0874/ABTC 02
Evanthia Galanis, S Keith Anderson, C Ryan Miller, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 12, 2007
Adult cancer pain
Robert Swarm, Doralina L Anghelescu, Costantino Benedetti, et al.
Journal for Immunotherapy of Cancer
|
August 12, 2021
Pembrolizumab for patients with leptomeningeal metastasis from solid tumors: efficacy, safety, and cerebrospinal fluid biomarkers
Jarushka Naidoo, Karisa C Schreck, Wei Fu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 17, 2025
Phase I Study of Adavosertib with Radiotherapy and Temozolomide in Newly Diagnosed Glioblastoma and Intratumoral Drug Levels in Recurrent Glioblastoma
Eudocia Q Lee, Brian M Alexander, Carlos G Romo, et al.
Neuro-Oncology
|
July 18, 2020
CODEL: phase III study of RT, RT + TMZ, or TMZ for newly diagnosed 1p/19q codeleted oligodendroglioma. Analysis from the initial study design
Kurt A Jaeckle, Karla V Ballman, Martin van den Bent, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 22, 2008
Central nervous system cancers
Steven S Brem, Philip J Bierman, Peter Black, et al.
Neuro-Oncology
|
August 12, 2021
Multimodal platform for assessing drug distribution and response in clinical trials
Begoña G C Lopez, Ishwar N Kohale, Ziming Du, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 1, 2005
Central nervous system cancers: Clinical Practice Guidelines in Oncology
Steven S Brem, Philip J Bierman, Peter Black, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 30, 2024
Surgical window of opportunity trial reveals mechanisms of response and resistance to navtemadlin (KRT-232) in patients with recurrent glioblastoma
Veronica Rendo, Eudocia Q Lee, Connor Bossi, et al.
Science Translational Medicine
|
February 19, 2025
A window-of-opportunity trial reveals mechanisms of response and resistance to navtemadlin in patients with recurrent glioblastoma
Veronica Rendo, Eudocia Q Lee, Connor Bossi, et al.
Page
of 18